[一种新型冠状血管及心脏活性物质的实验与临床研究] - Suppr | 超能文献

[Experimental and clinical studies with a new coronary and heart-active substance].

作者信息

Moll A, Petzel H

出版信息

Z Kreislaufforsch. 1967 Jan;56(1):46-58.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Experimental and clinical studies with a new coronary and heart-active substance].[一种新型冠状血管及心脏活性物质的实验与临床研究]

Z Kreislaufforsch. 1967 Jan;56(1):46-58.

2

[Clinical experimental studies with a new coronary and heart active beta-aminoketone].

Z Gesamte Inn Med. 1968 Apr 1;23(7):197-204.

3

[Clinical experiences with the use of carbochromen in coronary syndrome].

Arzneimittelforschung. 1970 Mar;20:454-6.

4

[Influence of "coronary dilators" on the pathological St-T segmental changes in the ECG].

Med Klin. 1967 Jun 16;62(24):945-50.

5

Clinical experience with a new coronary-active substance (BAY 1 1040).一种新型冠状活性物质（BAY 1 1040）的临床经验。

Arzneimittelforschung. 1972 Feb;22(2):380-9.

6

[Oxyphedrine in the treatment of coronary insufficiency: clinical evaluation].[去氧麻黄碱治疗冠状动脉供血不足：临床评估]

Arq Bras Cardiol. 1971 Apr;24(2):23-30.

7

[Carbochromen in therapy of acute and chronic coronary insufficiency].

Arzneimittelforschung. 1970 Mar;20:459-60.

8

[Clinical study of carbocromen (chromonar), new coronary vasodilator].新型冠状动脉扩张剂卡波铬（色满卡林）的临床研究

J Med Lyon. 1969 Mar 5;50(160):411-3.

9

[Therapy of coronary insufficiency with carbochromen].[用卡波罗孟治疗冠状动脉供血不足]

Arzneimittelforschung. 1970 Mar;20:456-9.

10

[Effect of oxyphedrine on hemodynamics and respiration].[麻黄碱对血流动力学和呼吸的影响]

Cas Lek Cesk. 1972 Dec 15;111(51):1201-5.

引用本文的文献

1

Effects of oxyfedrine and ouabain on the heart-lung preparation of the dog.奥昔非君和哇巴因对犬心肺制备标本的作用。

Naunyn Schmiedebergs Arch Pharmacol. 1973;277(1):89-102. doi: 10.1007/BF00498787.

2

Metabolism of oxyfedrine.奥昔非君的代谢

Naunyn Schmiedebergs Arch Pharmacol. 1972;275(3):323-37. doi: 10.1007/BF00500060.

3

Potentation of the cardiac response to aminophylline by oxyfedrine.

Naunyn Schmiedebergs Arch Pharmacol. 1975;287(1):11-22. doi: 10.1007/BF00632634.